Your browser doesn't support javascript.
loading
The Impact of Preventive Treatment for Multidrug- and Rifampin-Resistant Tuberculosis Exceeds Trial-Based Estimates.
Kasaie, Parastu; Pennington, Jeff; Gupta, Amita; Dowdy, David W; Kendall, Emily A.
Affiliation
  • Kasaie P; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Pennington J; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Gupta A; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Dowdy DW; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Kendall EA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Clin Infect Dis ; 78(1): 133-143, 2024 01 25.
Article in En | MEDLINE | ID: mdl-37724763
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rifampin / Tuberculosis, Multidrug-Resistant Type of study: Clinical_trials / Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rifampin / Tuberculosis, Multidrug-Resistant Type of study: Clinical_trials / Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos